Intraepidermal collections of neutrophils and lymphocytes are unique features of the in£ammatory reaction of psoriasis. Migration of leukocytes from dermis to the epidermis suggests a role for chemotactic agent(s). In recent years, increased levels of chemokines such as IL-8 , GRO-a and MCP-1 have been reported in the keratinocytes of psoriatic tissue. IL-8 and GRO-a belong to a subfamily (C6C) class and MCP-1 is a b chemokine. In this study, we investigated RANTES, which is a Þ chemokine (C-C class); RANTES has been found to be associated with various cell-mediated hypersensitive disorders. We obtained eight skin biopsies from chronic psoriatic plaques, and ¢ve biopsies each from nonlesional psoriatic skin, lichen planus, eczematous dermatitis and skin from healthy controls. Snap-frozen samples were cut into 7 mm cryosections and stained with 6 mg/ml of monoclonal anti-RANTES mouse IgG (DNAX, Palo Alto, CA). Standard immunohistochemistry techniques were applied. RANTES was detected only in the keratinocytes. The number of keratinocytes in per mm 2 of epidermis stained for RANTES were 116.79¡98.42 in psoriatic tissues compared to 32.00¡46.05 (pv0.05), 6.39¡3.59 (pv0.01), 2.64¡1.15 (pv0.01) and 3.53¡5.26 (pv0.01), respectively, in the nonlesional, lichen planus, eczematous lesions and normal skin. This is the ¢rst study to report that the keratinocytes of psoriatic tissue express high levels of RANTES compared to the controls. IL-8 and related molecules (C6C class) are predominantly chemotactic for neutrophils and MCP-1 is a strong chemotactic factor for monocytes. In contrast, RANTES is chemotactic for memory T cells and activated naive T cells. Increased amounts of RANTES as reported here provide an explanation for migration of the activated T cells to the epidermis of the psoriatic lesions. In addition, RANTES activates T cells. These results suggest that RANTES may have a signi¢cant role in the in£ammatory process of psoriasis. Our ¢ndings further substantiate a regulatory role for keratinocytes in the in£ammatory process of psoriasis.
Intraepidermal collections of neutrophils and lymphocytes are unique features of the in£ammatory reaction of psoriasis. Migration of leukocytes from dermis to the epidermis suggests a role for chemotactic agent(s). In recent years, increased levels of chemokines such as IL-8 , GRO-a and MCP-1 have been reported in the keratinocytes of psoriatic tissue. IL-8 and GRO-a belong to a subfamily (C6C) class and MCP-1 is a b chemokine. In this study, we investigated RANTES, which is a Þ chemokine (C-C class); RANTES has been found to be associated with various cell-mediated hypersensitive disorders. We obtained eight skin biopsies from chronic psoriatic plaques, and ¢ve biopsies each from nonlesional psoriatic skin, lichen planus, eczematous dermatitis and skin from healthy controls. Snap-frozen samples were cut into 7 mm cryosections and stained with 6 mg/ml of monoclonal anti-RANTES mouse IgG (DNAX, Palo Alto, CA). Standard immunohistochemistry techniques were applied. RANTES was detected only in the keratinocytes. The number of keratinocytes in per mm 2 of epidermis stained for RANTES were 116.79¡98.42 in psoriatic tissues compared to 32.00¡46.05 (pv0.05), 6.39¡3.59 (pv0.01), 2.64¡1.15 (pv0.01) and 3.53¡5.26 (pv0.01), respectively, in the nonlesional, lichen planus, eczematous lesions and normal skin. This is the ¢rst study to report that the keratinocytes of psoriatic tissue express high levels of RANTES compared to the controls. IL-8 and related molecules (C6C class) are predominantly chemotactic for neutrophils and MCP-1 is a strong chemotactic factor for monocytes. In contrast, RANTES is chemotactic for memory T cells and activated naive T cells. Increased amounts of RANTES as reported here provide an explanation for migration of the activated T cells to the epidermis of the psoriatic lesions. In addition, RANTES activates T cells. These results suggest that RANTES may have a signi¢cant role in the in£ammatory process of psoriasis. Our ¢ndings further substantiate a regulatory role for keratinocytes in the in£ammatory process of psoriasis. Key words: Þ chemokine; chemotaxis; cutaneous in£ammation. In recent years increased activity of chemokines such as IL-8, GRO-a and MCP-1 have been identi¢ed in the keratinocytes of psoriatic lesions (1^4). IL-8 and GRO-a belong to the a subfamily (C6C class) and MCP-1 is a Þ chemokine (C-C class). The present study was undertaken to investigate the activity of another Þ chemokine, RANTES (C-C class). Increased activity of RANTES has been reported in various in£ammatory conditions, such as rheumatoid arthritis (5), delayed-type hypersensitivity (6) and transplant rejection (7).
MATERIALS AND METHODS

Tissue preparation
Skin biopsies were obtained from chronic psoriatic plaque lesions (n8) , and ¢ve biopsies each from non-lesional psoriatic skin, lichen planus, eczematous dermatitis (three numular eczema, two contact dermatitis) and skin from healthy controls. Biopsies were taken from the edge of active psoriasis lesions that had not been receiving topical or systemic treatment for the prior 6 weeks. The samples were snap-frozen with liquid nitrogen and stored in refrigerator under^70³C.
The frozen samples were cut into 7 mm cryosections. The sections were mounted on glass slides and ¢xed in 4% formalin for 10 min at room temperature. The sections were washed and then sequentially blocked for endogenous biotin binding using the Vector blocking kit (Vector Laboratories, Burlingame, CA), and for endogenous peroxidase activity and non-speci¢c antibody binding sites with 3% hydrogen peroxide and 10% normal rabbit serum (Phoenix Pharmaceutical Inc., Mountain View, CA).
Immunohistochemistry staining
The sections were ¢rst incubated for 20 h with 6 mg/ml monoclonal anti-RANTES mouse IgG 2b (DNAX Research Institute, Palo Alto, CA) at room temperature. Mouse IgG 2b myleoma protein 6 mg/ml 2b (DNAX Research Institute, Palo Alto, CA) was used as an isotype control. Standard immunoperoxidase techniques were followed, secondary antibody along with color developing kits were bought from Phoenix Pharmaceutical Inc., Mountain View, CA. For negative controls except for using the primary anti-RANTES antibody the rest of the protocol was the same. In addition, we performed a preabsorption test of the RANTES-antibody to rule out non-speci¢c positivity.
RESULTS
Positive staining was observed in the tissues stained only with the monoclonal anti-RANTES antibody (Figs. 1^3) . Sections stained with the mouse IgG 2b (isotype control) and the sections which were stained with the RANTES antibody preabsorbed with RANTES did not show any positive staining for RANTES (Fig. 4) . All sections were examined by one investigator (WYJ) and independent con¢rmation of the numerical counting was performed by another investigator (SPRC). Cells in which staining could be appreciated without doubt were only considered to be positively stained. Cells Acta Derm Venereol (Stockh) 1999; 79: 9^11 which were slightly colored or where the positivity was doubtful were ignored. Tissues were examined for the presence of positively stained cells. RANTES was detected only in the keratinocytes. In psoriatic tissues keratinocytes expressed high levels of RANTES throughout all levels of epidermis except in stratum corneum (Fig. 1) . The number of cells positive for RANTES in per square mm of epidermis was calculated by dividing the total number of RANTES positive cells by the surface area. Surface area of the epidermis was determined with the help of a reticle/grid (10610 mm with 1 mm 2 boxes; Microscoptics, Inc., Milford, MI) placed in the eye piece. The data are described in Table I . The number of keratinocytes in per mm 2 of epidermis stained for RANTES was 116.79¡98.42 in psoriatic tissues compared with 32.00¡46.05 (pv0.05) , 6.39¡3.59 (pv0.01), 2.64¡1.15 (pv0.01) and 3.53¡5.26 (pv0.01) in non-lesional skin, lichen planus, eczematous lesions and normal skin, respectively. RANTES expression in the non-lesional psoriatic keratinocytes was relatively higher compared to the normal control skin, eczematous lesions and lichen planus lesions but did not reach statistical signi¢cance (p0.121, p0.446 and p0.141, respectively). Statistical analysis: Data in respect to cell counts are presented as mean¡SD (Table  I) ; for statistical analysis, the t-test was applied.
DISCUSSION
This is the ¢rst study to report that keratinocytes of psoriatic lesions express high levels of RANTES compared to the controls (Figs. 1^3) . Chemokines are produced by a variety of cells and their production is regulated by various proin£ammatory cytokines. RANTES is secreted by activated T lymphocytes, keratinocytes, ¢broblasts and epithelial cells subsequent to stimulation with TNF-a and IFN-a (8^11). Additional studies are required to determine whether the increased levels of RANTES in psoriatic keratinocytes is a secondary or a primary event. IL-8 and related molecules (C6C class) are predominantly chemotactic for neutrophils (7, 12, 13) and MCP-1/MCAF (monocyte chemotactic and activating factor) is predominantly a chemotactic protein for monocytes. Intradermal injection of IL-8 does not cause an accumulation of lymphocytes (14) . RANTES is chemotactic for resting CD4z memory T cells, and activated naive and memory T cells (13) . Increased activity of RANTES as reported in this study provides an explanation for the epidermotropism of activated T cells (151 7) in psoriatic tissue. In addition, RANTES activates T lymphocytes (7). Thus RANTES may have a signi¢cant role in the pathogenesis of psoriasis.
